Form 8-K - Current report:
SEC Accession No. 0000950170-25-085439
Filing Date
2025-06-12
Accepted
2025-06-12 16:27:12
Documents
14
Period of Report
2025-06-10
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20250610.htm   iXBRL 8-K 58205
2 EX-3.1 fgen-ex3_1.htm EX-3.1 59506
3 EX-99.1 fgen-ex99_1.htm EX-99.1 13432
4 GRAPHIC img145352098_0.jpg GRAPHIC 7707
5 GRAPHIC img145352098_1.jpg GRAPHIC 8097
  Complete submission text file 0000950170-25-085439.txt   272872

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20250610.xsd EX-101.SCH 25824
16 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20250610_htm.xml XML 4877
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 251043113
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)